Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals
Preferred Pharmaceuticals recalls specific lots of Ondansetron ODT 4mg tablets because blister packs are not fully sealed, risking lost medication.
Use caution until it’s fixed
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Contact the company
What happened, in plain English
Preferred Pharmaceuticals is recalling Ondansetron ODT Tablets, USP 4mg because the manufacturer Glenmark reported that the blister packs are not fully sealed. This defect can cause tablets to fall out of their packaging. The recall affects 575 foil blister packs distributed nationwide in the USA. Read more at govinfonow.com/recall/31635-preferred-pharma-recalls-ondansetron-odt-due-to-defective-seals.
Source Summary by GovInfoNow · govinfonow.com/recall/31635-preferred-pharma-recalls-ondansetron-odt-due-to-defective-seals · Updated October 9, 2026 · FDA enforcement record: FDA #D-0239-2026
Cite this page
“Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31635-preferred-pharma-recalls-ondansetron-odt-due-to-defective-seals. Based on FDA recall #D-0239-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0239-2026%22&limit=1).
Why it’s dangerous
The blister packs are not fully sealed, which allows the tablets to fall out. This means users may lose their medication or be unable to take the correct dose as intended.
Who’s affected
Patients who have purchased Ondansetron ODT Tablets, USP 4mg from Preferred Pharmaceuticals between unspecified dates and currently possess lots J1325J or I1725P with an expiration date of 4/30/2027.
How to tell if you have this one
Check your package for NDC 68788-8666-01 and verify if the lot number is J1325J or I1725P. The expiration date on the package should be 4/30/2027. The product was repackaged by Preferred Pharmaceuticals.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check your medication
Verify if your Ondansetron ODT Tablets match NDC 68788-8666-01 and lot numbers J1325J or I1725P.
Contact the manufacturer
Since no specific remedy is stated in the record, contact Preferred Pharmaceuticals or Glenmark for instructions on returns or replacements.
How this recall unfolded
Recall timeline
FDA published this recall 37 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Preferred Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0239-2026 (November 17, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0239-2026 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.